Ochre Bio
ochre-bio.comLocations
England, UK · Oxford, UK · Oxfordshire, UK
industry
Biotechnology
Size
51-200 employees
Stage
Series A
founded in
2019
Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.
Something looks off?Open jobs at Ochre Bio
On-site & Remote
Seniority
Salary